Search research articles
Contact Us
Filters
Showing results (111-120 of 132) with videos related to
Page
of 14
Sort By:
Cancers
|
May 13, 2026
Development and Characterization of a Novel Congenital Acute Erythroid Leukemia Cell Line with Unique Features
Prasiksha Sitaula, Manisha Gadgeel, Holly Edwards, et al.
Haematologica
|
March 2, 2019
Antileukemic activity and mechanism of action of the novel PI3K and histone deacetylase dual inhibitor CUDC-907 in acute myeloid leukemia
Xinyu Li, Yongwei Su, Gerard Madlambayan, et al.
Cancers
|
August 28, 2020
Cotargeting of Mitochondrial Complex I and Bcl-2 Shows Antileukemic Activity against Acute Myeloid Leukemia Cells Reliant on Oxidative Phosphorylation
Fangbing Liu, Hasini A Kalpage, Deying Wang, et al.
Blood
|
October 27, 2005
Differential gene expression, GATA1 target genes, and the chemotherapy sensitivity of Down syndrome megakaryocytic leukemia
Yubin Ge, Alan A Dombkowski, Katherine M LaFiura, et al.
Biochemical Pharmacology
|
October 8, 2022
Co-targeting of HDAC, PI3K, and Bcl-2 results in metabolic and transcriptional reprogramming and decreased mitochondrial function in acute myeloid leukemia
Katie Hege Hurrish, Xinan Qiao, Xinyu Li, et al.
Blood Cancer Journal
|
June 8, 2021
The combination of CUDC-907 and gilteritinib shows promising in vitro and in vivo antileukemic activity against FLT3-ITD AML
Xinan Qiao, Jun Ma, Tristan Knight, et al.
Haematologica
|
March 14, 2020
The HDAC and PI3K dual inhibitor CUDC-907 synergistically enhances the antileukemic activity of venetoclax in preclinical models of acute myeloid leukemia
Xinyu Li, Yongwei Su, Katie Hege, et al.
ASPET Discovery
|
July 9, 2026
Targeting ribonucleotide reductase to enhance the antileukemic activity of gilteritinib against chemoresistant <i>FLT3</i>- internal tandem duplication acute myeloid leukemia
Nibal Eid, Jianlei Zhao, Jenna Thibodeau, et al.
Leukemia Research
|
July 13, 2019
Interleukin-8 blockade prevents activated endothelial cell mediated proliferation and chemoresistance of acute myeloid leukemia
Vindhya Vijay, Regan Miller, Gau Shoua Vue, et al.
Blood
|
December 24, 2014
MicroRNA-486-5p is an erythroid oncomiR of the myeloid leukemias of Down syndrome
Lital Shaham, Elena Vendramini, Yubin Ge, et al.
Page
of 14
Search research articles
Search
Showing results (111-120 of 132) with videos related to
Sort By:
Page
of 14
Cancers
|
May 13, 2026
Development and Characterization of a Novel Congenital Acute Erythroid Leukemia Cell Line with Unique Features
Prasiksha Sitaula, Manisha Gadgeel, Holly Edwards, et al.
Haematologica
|
March 2, 2019
Antileukemic activity and mechanism of action of the novel PI3K and histone deacetylase dual inhibitor CUDC-907 in acute myeloid leukemia
Xinyu Li, Yongwei Su, Gerard Madlambayan, et al.
Cancers
|
August 28, 2020
Cotargeting of Mitochondrial Complex I and Bcl-2 Shows Antileukemic Activity against Acute Myeloid Leukemia Cells Reliant on Oxidative Phosphorylation
Fangbing Liu, Hasini A Kalpage, Deying Wang, et al.
Blood
|
October 27, 2005
Differential gene expression, GATA1 target genes, and the chemotherapy sensitivity of Down syndrome megakaryocytic leukemia
Yubin Ge, Alan A Dombkowski, Katherine M LaFiura, et al.
Biochemical Pharmacology
|
October 8, 2022
Co-targeting of HDAC, PI3K, and Bcl-2 results in metabolic and transcriptional reprogramming and decreased mitochondrial function in acute myeloid leukemia
Katie Hege Hurrish, Xinan Qiao, Xinyu Li, et al.
Blood Cancer Journal
|
June 8, 2021
The combination of CUDC-907 and gilteritinib shows promising in vitro and in vivo antileukemic activity against FLT3-ITD AML
Xinan Qiao, Jun Ma, Tristan Knight, et al.
Haematologica
|
March 14, 2020
The HDAC and PI3K dual inhibitor CUDC-907 synergistically enhances the antileukemic activity of venetoclax in preclinical models of acute myeloid leukemia
Xinyu Li, Yongwei Su, Katie Hege, et al.
ASPET Discovery
|
July 9, 2026
Targeting ribonucleotide reductase to enhance the antileukemic activity of gilteritinib against chemoresistant <i>FLT3</i>- internal tandem duplication acute myeloid leukemia
Nibal Eid, Jianlei Zhao, Jenna Thibodeau, et al.
Leukemia Research
|
July 13, 2019
Interleukin-8 blockade prevents activated endothelial cell mediated proliferation and chemoresistance of acute myeloid leukemia
Vindhya Vijay, Regan Miller, Gau Shoua Vue, et al.
Blood
|
December 24, 2014
MicroRNA-486-5p is an erythroid oncomiR of the myeloid leukemias of Down syndrome
Lital Shaham, Elena Vendramini, Yubin Ge, et al.
Page
of 14